• Home
  • About Us
  • Clinical trials
  • News
  • Contacts
+7 (495)105 99 05 crd@ollamed.ru
  • Русский (Россия)
  • English (United Kingdom)
Департамент Клинических Исследований ООО Департамент Клинических Исследований ООО Департамент Клинических Исследований ООО
  • Home
  • About Us
  • Clinical trials
  • News
  • Contacts
Департамент Клинических Исследований ООО Департамент Клинических Исследований ООО Департамент Клинических Исследований ООО
  • Home
  • About Us
  • Clinical trials
  • News
  • Contacts

News

  • Home /
  • News /
  • Information /
  • Cooperation with Biogen

Cooperation with Biogen

Super User
Information
Read Time: 1 min
Created: 06 April 2021
Hits: 0

Our Study Site was invited to participate in clinical trials conducted by the international pharmaceutical company Biogen.

Search

Sections

  • Progress

  • Trials

  • Information

Last news

  • Completion of the study 25 Jun 2025
  • Evaluation of the possibility of conducting clinical trials of vaccines for the prevention of meningococcal and pneumococcal infections in the pediatric population. 06 May 2025
  • The visit of the selection center to participate in two studies of biological drugs for the treatment of IBD has been successfully completed. 08 Apr 2025

Our partners

Protagonist
Gilead
Mithra
PRA Health Sciences
Pfizer
Rusmo-AG
Sanofi
Abbvie
Icon
Astra Zeneca
Gedeon Richter
Cromos Pharma
PPD
X7 Research
Synteract
IQVIA
Biorasi | Built for Faster Clinical Trials
PSI
ALK
Galecto
SRG
Clinipas
Astellas
Janssen
JonsonAndJonson
OCT
Celgen
Bristol-Myers Squibb Company
Biogen
Contact US
  • 8 (800) 444 06 68
  • ctd@ollamed.ru
  • 8А, 9-ya Parkovaya st., Moscow, Russia
  • Working time: 9:00-18:00 Mo-Fr

News

  • Completion of the study 25 Jun 2025
  • Evaluation of the possibility of conducting clinical trials of vaccines for the prevention of meningococcal and pneumococcal infections in the pediatric population. 06 May 2025
  • The visit of the selection center to participate in two studies of biological drugs for the treatment of IBD has been successfully completed. 08 Apr 2025
Copyright © 2025 Clinical trials department LLC "OLLA-MED"